News | October 18, 2009

Hologic Raises Breast Cancer Awareness with "Promise to Me"

October 19, 2009 - When Jack Cumming, Hologic Chairman and CEO, presided over the NASDAQ opening bell ceremony in New York City on
Thursday, October 1, 2009 at 9:30 a.m. (EST) for the fourth consecutive year to honor the National Breast Cancer Awareness Month, the company also kicked off the "Promise to Me" campaign.

The initiative is focused on increasing awareness of the importance of breast cancer screening and Hologic's funding of mammograms for underserved women. The American Cancer Society estimates more than 240,000 new cases of breast cancer are diagnosed in the U.S. each year, with one of eight women being inflicted with this deadly disease in her lifetime.

"These statistics are overwhelming and we remain deeply
committed to helping women worldwide who are afflicted by this dreadful disease," said Mr. Cumming. "Breast cancer screening programs and technologies, such as digital mammography, have gone a long way toward decreasing death rates from breast cancer and we will continue to do so not only with our current technology, but with the
introduction of ."

Hologic is a leader in digital mammography systems with over 5,000 Selenia systems shipped. Hologic also offers new technologies such as our 3-D Selenia Dimensions digital tomosynthesis system.

The focus of the Promise to Me campaign is to empower women to take ownership of their health, starting with scheduling an annual mammogram. Program details are available at www.promisetome.com. Through this initiative, Hologic has committed to support women who are unable to afford mammograms, and the company has done so through a partnership with Remote Area Medical (RAM), a non-profit, volunteer organization dedicated to bringing healthcare services to
underserved populations in remote areas in the U.S. and abroad.

For more information: www.hologic.com and www.promisetome.com

Related Content

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...